eMed Technologies is moving ahead with plans to expand its portfolio of Internet-based products and services, fueled in large part by the prospect of a pending $46 million initial public offering. The Lexington, MA-based company originally filed for an
eMed Technologies is moving ahead with plans to expand its portfolio of Internet-based products and services, fueled in large part by the prospect of a pending $46 million initial public offering. The Lexington, MA-based company originally filed for an IPO last August (SCAN 9/1/99) but postponed the offering just one month later, citing market volatility with regard to health-related IPOs (SCAN 10/27/99).
Apparently sensing a more positive climate on Wall Street these days, eMed refiled its IPO with the Securities and Exchange Commission Feb. 25 (SCAN 9/1/99). If the public offering goes through, the company will trade on NASDAQ under the symbol EMDT.
Founded in early 1992, eMed (then known as Access Radiology) had a modest beginning, generating just $139,000 in revenue. But the company has experienced strong growth in the last three years, with revenue increasing from $1 million in 1996 to $23.6 million in 1999. The bulk of its current revenue stems from its Framewave product line.
eMed has been unable to translate its skyrocketing revenue into profitability, however, although its losses are decreasing annually. The company posted a loss of $5.6 million in 1997, $5.1 million in 1998, and $2.6 million in 1999. In addition, eMed expects to see revenue and profit increases in the coming year from its growing stable of Internet- and Web-based products and services (SCAN 1/12/00). These include eMed.net, a subscription-based Internet Web site development and hosting service, and Images by eMed, a brand name under which the company will offer its technology to other vendors, enabling them to distribute medical images through their Internet-based applications.
eMeds recent acquisition of Trilix Information Systems, a systems integration software developer founded by several former Cemax-Icon engineers, is also expected to boost the companys bottom line in the coming year. Trilix, headquartered in Pleasanton, CA, provides integration technology that allows the exchange of information among different healthcare imaging and information systems, both within a hospitals network and via the Internet.
The addition of Trilixs technology to eMeds image-management products and services should help facilitate an organizations move toward electronic patient records, providing clinicians with connectivity to diagnostic images, as well as to laboratory, pathology, and other diagnostic reports, according to Howard Pinsky, chief technology office for eMed.
eMed also plans to make Trilixs interface technologies available to other vendors on an OEM basis. Trilix already has OEM relationships with Kodak and Canon, according to company sources. eMed acquired Trilix in a straight stock deal.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.